Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Multimodal virtual reality program to reduce anxiety before cancer surgery

Official title: Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients

Run by University of Manitoba · NCT07366515 · Data updated 2026-11-12

This study will try a virtual reality program to see if it reduces anxiety for adults preparing for cancer surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Manitoba
Academic / other
Locations1 site (Winnipeg, Manitoba)
StatusRecruiting
StartedApril 22, 2026
Main results expectedJune 1, 2026
Study endsJune 30, 2026
Registry record updatedMay 5, 2026
Trial IDNCT07366515 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who read and speak English, have a cancer diagnosis, and are scheduled for oncologic surgery under general anesthesia at Health Sciences Centre Winnipeg who can provide informed consent and use VR.

Probably not a fit

Patients who cannot provide informed consent or who have visual, auditory, or motor impairments that prevent effective VR participation, as well as non-English speakers or those having surgery elsewhere, are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a feasibility trial at Health Sciences Centre Winnipeg testing an expanded multimodal virtual reality (VR) intervention delivered before oncologic surgery. The team will measure feasibility by tracking recruitment, retention, engagement, and participant feedback on each VR component, and will monitor for any adverse effects. Investigators will explore whether baseline anxiety or psychiatric history predicts response and whether providing first-person VR session recordings for later access is useful. Preliminary pilot outcomes will examine whether greater engagement with the VR intervention is associated with lower anxiety on the day of surgery.

Why it matters

Potential benefit: If successful, the intervention could lower preoperative anxiety and distress for cancer surgery patients, improving the perioperative experience and possibly recovery.

How similar studies have gone: Prior studies using VR for perioperative anxiety have shown mixed but generally promising reductions in anxiety, although the use of a multimodal program with recorded first-person session access is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Patients will be deemed eligible for inclusion if they: (a) are 18 years of age or older; (b) are able to speak and read English; (c) have received a cancer diagnosis; and (d) are scheduled, or in the process of being scheduled to undergo oncological surgery under general anesthesia at the Health Sciences Centre Winnipeg. Patients will be deemed ineligible if they are unable to provide informed consent (e.g., due to cognitive impairment) or if they have any visual, auditory and/or motor impairments that would preclude effective participation in the Virtual Reality intervention.

Where it's running

  • Health Sciences Centre
    Winnipeg, Manitoba, Canada
    Recruiting

Study contacts

  • Principal investigator: Renee El-Gabalawy, PhD — University of Manitoba
  • Study coordinator: Cassidy Santos, BA (Hons.)
  • Email: csantos17@hsc.mb.ca
  • Phone: 204-787-7424

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.